GRCL – gracell biotechnologies inc. - american depositary shares (US:NASDAQ)
Stock Stats
News
Gracell Biotechnologies Inc. (NASDAQ: GRCL) had its "hold" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $10.25 price target on the stock, down previously from $11.00.
Gracell Biotechnologies Acquisition Completed
Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement
Astra Sees Stronger Profit, Sales Growth on Cancer Drugs [BNN Bloomberg (Canada)]
Form 25-NSE Gracell Biotechnologies Filed by: Nasdaq Stock Market LLC
Form 6-K Gracell Biotechnologies For: Feb 22
Form 6-K Gracell Biotechnologies For: Feb 20
Form SC 13G/A Gracell Biotechnologies Filed by: RA CAPITAL MANAGEMENT, L.P.
Form SC 13G/A Gracell Biotechnologies Filed by: William Cao Wei
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.